Abstract
Bendamustine is an alkylator with anticipated antimetabolic activity. It has shown activity in malignant lymphoma, multiple myeloma, and breast cancer. Recognized side-effects are relatively mild with myelosuppression as the dose-limiting toxicity. The CD4/CD8 ratio may be reduced. To what extent the alteration of lymphocytes, especially CD4(+) lymphocytes, correlates with an increase in opportunistic infections cannot be definitively answered. The patient, female, aged 48 years, was suffering from an advanced progressive breast cancer. After initial treatment with several chemotherapies, a cytotoxic therapy was initiated, with bendamustine (150 mg/m(2)) administered on two consecutive days and repeated every 4 weeks. After five courses, the patient developed Pneumocystis carinii pneumonia (PCP), disclosed in the bronchoalveolar lavage. While receiving bendamustine therapy, the CD4(+) and CD8(+) lymphocyte counts in the peripheral blood were determined by flow cytometry. The next-to-normal CD4/CD8 ratio before therapy (0,82) had decreased to 0,05 during the therapy mainly due to a decline of CD4(+) lymphocyte. The patient was seronegative for human immunodeficiency virus. In spite of high-dose intravenous trimethoprim/sulfameth...Continue Reading
References
Feb 1, 1991·The American Review of Respiratory Disease·J SiminskiG Raghu
Jan 18, 1990·The New England Journal of Medicine·J PhairA Saah
May 1, 1993·European Journal of Haematology·P W WijermansH L Haak
Feb 1, 1993·Respiratory Medicine·G C KaneH L Israel
Jun 1, 1996·Anti-cancer Drugs·D StrumbergS Seeber
Dec 22, 1998·Journal of Cancer Research and Clinical Oncology·K HöffkenS Seeber
Dec 28, 1999·Leukemia & Lymphoma·J N BastieS Castaigne
Jan 21, 2000·Journal of Cancer Research and Clinical Oncology·P SchöffskiA Ganser
Aug 15, 2000·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P SchöffskiA Ganser
Aug 29, 2000·Infection·T GlückJ Schölmerich
Feb 24, 2001·Journal of Cancer Research and Clinical Oncology·R KathK Höffken
Mar 21, 2001·Deutsche medizinische Wochenschrift·R KathK Höffken
May 24, 2001·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·A N RahnH D Böttcher
Citations
Oct 30, 2007·Journal of Medical Case Reports·Cai ChuangZhong Nanshan
Feb 23, 2013·Cancer Chemotherapy and Pharmacology·Rachel M LaymanCharles L Shapiro
Apr 30, 2013·Emerging Infectious Diseases·Rishma MainiNick Phin
Jul 30, 2005·Scandinavian Journal of Infectious Diseases·Donato TorrePiero Rapazzini
Jul 4, 2007·Transplant Infectious Disease : an Official Journal of the Transplantation Society·D Bandt, S Monecke
Feb 11, 2011·Leukemia & Lymphoma·Umit TapanOlga Kozyreva
Apr 12, 2011·Wiener klinische Wochenschrift·Christian WaldthalerMichael Fiegl
Apr 19, 2011·Expert Review of Hematology·Leslie A Andritsos, Michael R Grever
Oct 12, 2011·Current Opinion in Infectious Diseases·Alistair B ReidLeon J Worth
Mar 16, 2012·International Journal of Hematology·Yutaka TsutsumiMasahiro Imamura
Jun 12, 2012·International Journal of Hematology·Sean WarschIzidore S Lossos
Jun 14, 2013·Case Reports in Oncological Medicine·Tsuyoshi ShinoharaKiyofumi Yamagishi
Apr 29, 2015·Clinical Case Reports·Tarig Mohammed AbkurDenis O'Keeffe
Feb 14, 2015·Annals of Hematology·P CougoulV Sibaud
Dec 24, 2015·Leukemia & Lymphoma·Anat Gafter-Gvili, Aaron Polliack
Apr 23, 2016·Blood Research·Jeonghoon HaInsook Woo
Sep 14, 2012·Expert Opinion on Drug Metabolism & Toxicology·Anna Korycka-Wołowiec, Tadeusz Robak
Mar 15, 2005·Scandinavian Journal of Infectious Diseases·France RoblotFrancois Guilhot
Nov 22, 2017·Expert Review of Hematology·Tamar TadmorIwona Hus
Jun 23, 2021·Cancer Medicine·Mikhaila L RiceAndrew H Limper